Table 2.
Comparisons of Baseline Characteristics by Stroke Risk and Sex
| Risk Factor 0 | Risk Factor 1 | Risk Factor ≥2 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Men (n=95) | Women (n=53) | P Value | Men (n=89) | Women (n=48) | P Value | Men (n=179) | Women (n=115) | P Value | |
| Age, y | 53.1±8.4 | 52.7±8.9 | 0.821 | 58.0±8.2 | 59.9±7.2 | 0.184 | 66.8±8.7 | 67.0±7.8 | 0.851 |
| Paroxysmal AF, n (%) | 73 (76.8) | 41 (77.4) | 0.943 | 60 (67.4) | 39 (81.2) | 0.110 | 119 (66.5) | 74 (64.3) | 0.708 |
| Body mass index, kg/m2 | 24.8±2.6 | 23.9±3.1 | 0.053 | 25.1±3.0 | 24.1±2.6 | 0.066 | 24.5±2.4 | 25.3±3.0 | 0.012a |
| eGFR, mL/min per 1.73 m2 | 83.8±12.1 | 88.8±14.8 | 0.026a | 81.5±15.0 | 80.9±19.1 | 0.829 | 72.5±19.1 | 73.0±19.1 | 0.839 |
| Risk factors | |||||||||
| Congestive heart failure, n (%) | 0 (0.0) | 0 (0.0) | — | 5 (5.6) | 5 (10.4) | 0.320 | 28 (15.6) | 17 (14.8) | 0.870 |
| Hypertension, n (%) | 0 (0.0) | 0 (0.0) | — | 61 (68.5) | 25 (52.1) | 0.066 | 138 (77.1) | 90 (78.3) | 0.886 |
| 65≤ Age <75, n (%) | 0 (0.0) | 0 (0.0) | — | 18 (20.2) | 16 (33.3) | 0.101 | 86 (48.0) | 54 (47.0) | 0.905 |
| Age ≥75, n (%) | 0 (0.0) | 0 (0.0) | — | 0 (0.0) | 0 (0.0) | — | 36 (20.1) | 22 (19.1) | 0.882 |
| Diabetes mellitus, n (%) | 0 (0.0) | 0 (0.0) | — | 2 (2.2) | 2 (4.2) | 0.612 | 51 (28.5) | 32 (27.8) | 0.902 |
| Stroke or TIA, n (%) | 0 (0.0) | 0 (0.0) | — | 0 (0.0) | 0 (0.0) | — | 59 (33.0) | 45 (39.1) | 0.318 |
| Vascular disease, n (%) | 0 (0.0) | 0 (0.0) | — | 3 (3.4) | 0 (0.0) | 0.552 | 57 (31.8) | 29 (25.2) | 0.239 |
| Medications | |||||||||
| ACEi/ARB (%) | 3 (3.2) | 3 (5.7) | 0.667 | 45 (50.6) | 15 (31.2) | 0.032a | 92 (51.4) | 62 (53.9) | 0.720 |
| β‐blocker (%) | 14 (14.7) | 13 (24.5) | 0.183 | 24 (27.0) | 12 (25.0) | 0.842 | 70 (39.1) | 42 (36.5) | 0.713 |
| Statin (%) | 9 (9.5) | 6 (11.3) | 0.779 | 19 (21.3) | 13 (27.1) | 0.527 | 80 (44.7) | 58 (50.4) | 0.341 |
ACEi indicates angiotensin‐converting enzyme inhibitor; AF, atrial fibrillation; ARB, angiotensin II receptor blocker; eGFR, estimated glomerular filtration rate; TIA, transient ischemic attack.
a
P<0.05.